Nowadays, RTI-171 is a topic that has captured the attention of people all over the world. Whether due to its impact on society, its historical relevance or its influence on everyday life, RTI-171 has generated growing interest in different sectors. In this article, we will explore in depth the most relevant aspects of RTI-171, from its origin to its evolution today. We will analyze its implications, its challenges and the possible solutions that have been proposed to address this issue. Additionally, we will examine expert opinions and the experiences of individuals who have been affected by RTI-171. Get ready to immerse yourself in a complete and enriching analysis of RTI-171!
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H24N2O |
Molar mass | 296.414 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
(–)-2β-(3-Methylisoxazol-5-yl)-3β-(p-tolyl)tropane (RTI-4229-171) is a phenyltropane derivative which acts as a selective dopamine reuptake inhibitor, with a relatively slow onset of action and short duration of effects found in animal studies.[1] However, other studies have shown it to have the most pronounced effects in terms of speed of onset and rate of stimulation among many differing phenyltropanes.[2]